Post Reply
61-80 of 657
https://www.stocksbnb.com/reports/health-management-international-a-visit-to-the-crown-jewel-in-melaka/
https://s3-ap-southeast-1.amazonaws.com/investingnote-production-webbucket/attachments/9667202d9800ef5841cc555c23bba56cadcb6f6f.pdf?1494814621
trading volume very low.
Yes look like don't want hmi going up
westpoison ( Date: 08-May-2017 15:22) Posted:
|
look out for result tomorrow. share price shd be up
Why CIMB likes this lesser-known heathcare operator
By:
Jude Chan
09/05/17, 12:47 pm
SINGAPORE (May 9): With a healthy local patient demand and a growing medical tourism market, CIMB Research believes Malaysia-based private healthcare operator Health Management International (HMI) could well be a cheaper hospital play compared to its peers.
CIMB is keeping its &ldquo add&rdquo recommendation on HMI with an unchanged target price of 81 cents ahead of its scheduled 3Q17 results announcement on May 11.
This is despite HMI&rsquo s 3Q headline earnings expected to be dragged by one-off items arising from professional fees related to minority interests&rsquo consolidation.
According to CIMB analyst Ngoh Yi Sin, HMI is trading at 14.1x CY17 EV/EBITDA, lower than the industry average of 22.3x.
Following a visit to its key hospital assets in Malaysia &ndash Regency Specialist Hospital (RSH) in Johor and Mahkota Medical Centre (MMC) in Malacca &ndash as well as their neighbouring competitor hospitals, Ngoh says HMI is an &ldquo outperformer&rdquo relative to its peers.
&ldquo We were impressed with HMI&rsquo s healthcare facilities, patient footfall, and overall strategy,&rdquo she says in a report on Monday.
According to Ngoh, HMI had superior healthcare facilities to KPJ Johor Specialist Hospital, and higher patient footfall than Gleneagles Medini and Pantai Hospital Ayer Keroh.
&ldquo There was visibly greater patient volume at RSH,&rdquo says Ngoh, &ldquo while a new hospital extension is underway to meet higher demand by 2020.&rdquo
&ldquo An increasing number of Singaporean patients (mainly for health screening and elective procedures) remains an untapped patient pool for RSH, as it focuses on the existential demand gap in Johor,&rdquo she adds.
Meanwhile, Ngoh believes MMC could have the potential to grow its medical tourism market share. Already, MMC is one of the leading medical tourism players in Malaysia, with close to 10% of market share.
In addition, HMI could benefit from developments in Johor and Malacca, including Iskandar Malaysia and Melaka Gateway, which would boost the regions and enlarge the hospital operator&rsquo s future patient pool.
Ngoh adds that HMI&rsquo s local patient demand will also be driven by growing affluence in Malaysia and an increasing penetration of insurance coverage.
As at 12.45pm, shares of Health Management International are trading 1 cent lower at 60.5 cents.
https://s3-ap-southeast-1.amazonaws.com/investingnote-production-webbucket/attachments/1e0c6f30627f4431c38c47d266347c3d94ab5a2d.pdf?1494291883
if can keep long term , at 61 cents still a good buy. Once the hospital expansion completed, price shd go up to around 80 cents
somebody or keep selling down 100 units by 100 units huh.
Oooo... 595
http://aspire.sharesinv.com/41920/singapore-based-hmi-shares-skyrocket-with-no-signs-of-slowing/
Keep got people sell down 100units by 100units...
jessliew ( Date: 11-Apr-2017 15:21) Posted:
|
Health Management International Ltd?s Stock Is Up 517% In 5 Years: Here Are 3 Things Investors Should Know
Lawrence Nga | April 11, 2017 | More on: 588
Health Management International Ltd (SGX: 588) is a healthcare services provider with a presence in Singapore, Malaysia, and Indonesia.
It owns and operates two hospitals in Malaysia (the Mahkota Medical Centre in Malacca and Regency Specialist Hospital in Iskandar Malaysia) with a total bed capacity of more than 500.
The company also has a healthcare training centre in Singapore, the HMI Institute of Health Sciences. It provides Skills Future Singapore accredited training courses for the healthcare support sector.
Over the past five years, Health Management International?s stock price has climbed by a massive 517%. This led me to take a closer look at the company?s business. Here are three things I found that may interest investors:
1. Solid business growth
From its FY2012 (fiscal year ended 30 June 2012) to FY2016, Healthcare Management has grown its revenue from RM 209.2 million to RM 397.8 million. This translates to an impressive compound annual growth rate of 17.4%. Over the same time frame, the company?s net profit attributable to shareholders grew even faster, from a negative RM 0.5 million to a positive RM 19.9 million.
2. An above-average return on equity
The return on equity (ROE) metric measures a company?s ability to generate a profit with the shareholder?s capital it has. In general, a high ROE (without the presence of high levels of debt) comes together with a quality business.
Right now, the median trailing ROE for the 30 companies that make up Singapore?s stock market benchmark, the Straits Times Index (SGX: ^STI), is less than 10%, according to data from S&P Global Market Intelligence. But, Health Management managed to generate a ROE of 14.4% in the last 12 months.
3. The presence of owner-operators in the company
Dr Gan See Khem and her family (this includes her husband and children) collectively control 52.08% of Health Management?s total shares as of 19 September 2016. Dr Gan is the company?s executive chairman and managing director. Her children, Chin Wei Jia and Chin Wei Yao, are the company?s chief executive officer and chief financial officer, respectively.
So as you can see, Health Management is a company whereby the management team is made up of controlling shareholders.
Though it can be difficult to judge whether management?s interests are aligned with minority shareholders, there?s one thing we can be certain of. Minority shareholders of Health Management has benefited greatly over the past five years given the aforementioned 517% gain in the company?s stock price.
from The Motley Fool's weekly investing newsletter
Lawrence Nga | April 11, 2017 | More on: 588
Health Management International Ltd (SGX: 588) is a healthcare services provider with a presence in Singapore, Malaysia, and Indonesia.
It owns and operates two hospitals in Malaysia (the Mahkota Medical Centre in Malacca and Regency Specialist Hospital in Iskandar Malaysia) with a total bed capacity of more than 500.
The company also has a healthcare training centre in Singapore, the HMI Institute of Health Sciences. It provides Skills Future Singapore accredited training courses for the healthcare support sector.
Over the past five years, Health Management International?s stock price has climbed by a massive 517%. This led me to take a closer look at the company?s business. Here are three things I found that may interest investors:
1. Solid business growth
From its FY2012 (fiscal year ended 30 June 2012) to FY2016, Healthcare Management has grown its revenue from RM 209.2 million to RM 397.8 million. This translates to an impressive compound annual growth rate of 17.4%. Over the same time frame, the company?s net profit attributable to shareholders grew even faster, from a negative RM 0.5 million to a positive RM 19.9 million.
2. An above-average return on equity
The return on equity (ROE) metric measures a company?s ability to generate a profit with the shareholder?s capital it has. In general, a high ROE (without the presence of high levels of debt) comes together with a quality business.
Right now, the median trailing ROE for the 30 companies that make up Singapore?s stock market benchmark, the Straits Times Index (SGX: ^STI), is less than 10%, according to data from S&P Global Market Intelligence. But, Health Management managed to generate a ROE of 14.4% in the last 12 months.
3. The presence of owner-operators in the company
Dr Gan See Khem and her family (this includes her husband and children) collectively control 52.08% of Health Management?s total shares as of 19 September 2016. Dr Gan is the company?s executive chairman and managing director. Her children, Chin Wei Jia and Chin Wei Yao, are the company?s chief executive officer and chief financial officer, respectively.
So as you can see, Health Management is a company whereby the management team is made up of controlling shareholders.
Though it can be difficult to judge whether management?s interests are aligned with minority shareholders, there?s one thing we can be certain of. Minority shareholders of Health Management has benefited greatly over the past five years given the aforementioned 517% gain in the company?s stock price.
from The Motley Fool's weekly investing newsletter
Is it a good time to buy this?
Bought a few lots at $0.635 today and most are coming from foreign brokers (Credit Suisse, Goldman Sachs, UBS). Wow.
Before May? So confident..
Trader101 ( Date: 22-Mar-2017 20:37) Posted:
|
Hello Jess, if you have noticed, it up soooo much on 20 Mar before noon, it just dropped back to the normal range in the evening before closing. I' d say that was the effect created by shortist.
Even though all the index turns red today, HMI has just a slightly drop compare to other counters. To me, it takes time to get profit from every counter. Myself looking for long term investment. I would say this counter got very much potential, and it will continue go up till or beyond $0.800 before May.
Cheers
jessliew ( Date: 20-Mar-2017 16:51) Posted:
|
Today drop so much... Look like hard to reach even $0.700
Trader101 ( Date: 19-Mar-2017 14:58) Posted:
|
This stock keeps moving upwards, tp at 0.83 but I see it should be at least 0.95.
" In November last year, HMI had announced that it had agreed to raise its stakes in its 49 per cent-owned Mahkota Medical Centre (MMC) and 61 per cent-owned Regency Specialist Hospital (RSH) to 100 per cent each. This will be for an aggregate price of RM556.5 million (about S$183.2 million)."
See how confidence HMI is on their business plan and growth.
those who took up right already made 10 cents per share